Abstract
Repairing the biology is fundamental to improve the quality of the damaged tissue, making the recovery period more comfortable and shorter. This is done by biological therapies based on three elements; three-dimensional scaffolds, cells and signalling molecules. The main role of three-dimensional scaffolds is to be the support where de cells adhere, they are also bioactive and interact, attract and stimulate those cells. One of the major focuses in regenerative medicine are cell-therapies, that depending on their collection source they have different characteristics. All the biological events basic for the success when regenerating are controlled by signalling molecules. The biological pathways are immediately activated after a tissue injury, using the Growth Factors we are capable of modulate this response. They are involved in biological functions, such as cellular proliferation, cellular survival, migration and even apoptosis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Breuls RGM, Jiya TU, Smit TH. Scaffold stiffness influences cell behavior: opportunities for skeletal tissue engineering. Open Orthop J. 2008;2:103–9. doi:10.2174/1874325000802010103.
Zuk PA, Zhu M, Ashjian P, et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell. 2002;13:4279–95. doi:10.1091/mbc.E02-02-0105.
Zuk PA, Zhu M, Mizuno H, et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng. 2001;7:211–28. doi:10.1089/107632701300062859.
Kachgal S, Putnam AJ. Mesenchymal stem cells from adipose and bone marrow promote angiogenesis via distinct cytokine and protease expression mechanisms. Angiogenesis. 2011;14:47–59. doi:10.1007/s10456-010-9194-9.
Rehman J, Traktuev D, Li J, et al. Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Circulation. 2004;109:1292–8. doi:10.1161/01.CIR.0000121425.42966.F1.
Hong SJ, Traktuev DO, March KL. Therapeutic potential of adipose-derived stem cells in vascular growth and tissue repair. Curr Opin Organ Transplant. 2010;15:86–91. doi:10.1097/MOT.0b013e328334f074.
Wong VW, Levi B, Rajadas J, et al. Stem cell niches for skin regeneration. Int J Biomater. 2012;2012:926059. doi:10.1155/2012/926059.
Koh Y-G, Choi Y-J. Infrapatellar fat pad-derived mesenchymal stem cell therapy for knee osteoarthritis. Knee. 2012;19:902–7. doi:10.1016/j.knee.2012.04.001.
Liu Y-P, Li S-Z, Yuan F, et al. Infrapatellar fat pad may be with tendon repairing ability and closely related with the developing process of patella Baja. Med Hypotheses. 2011;77:620–3. doi:10.1016/j.mehy.2011.06.048.
Gigante A, Cecconi S, Calcagno S, et al. Arthroscopic knee cartilage repair with covered microfracture and bone marrow concentrate. Arthrosc Tech. 2012;1:e175–80. doi:10.1016/j.eats.2012.07.001.
Pascual-Garrido C, Rolón A, Makino A. Treatment of chronic patellar tendinopathy with autologous bone marrow stem cells: a 5-year-followup. Stem Cells Int. 2012;2012:1–5. doi:10.1155/2012/953510.
Gobbi A, Karnatzikos G, Sankineani SR. One-step surgery with multipotent stem cells for the treatment of large full-thickness chondral defects of the knee. Am J Sports Med. 2014;42:648–57. doi:10.1177/0363546513518007.
Le Nail L-R, Stanovici J, Fournier J, et al. Percutaneous grafting with bone marrow autologous concentrate for open tibia fractures: analysis of forty three cases and literature review. Int Orthop. 2014;38:1845–53. doi:10.1007/s00264-014-2342-x.
Pettine KA, Murphy MB, Suzuki RK, Sand TT. Percutaneous injection of autologous bone marrow concentrate cells significantly reduces lumbar discogenic pain through 12 months. Stem Cells. 2015;33:146–56. doi:10.1002/stem.1845.
Pettine K, Suzuki R, Sand T, Murphy M. Treatment of discogenic back pain with autologous bone marrow concentrate injection with minimum two year follow-up. Int Orthop. 2016;40:135–40. doi:10.1007/s00264-015-2886-4.
Rodriguez L, Seijas R, Codinach M, Torrents S, Cuscó X, García J, Cugat R. Processing volumes and therapeutic cellular doses of point of care bone marrow concentrates. Int J Orthop. 2016;3:621–6. doi: 10.17554/j.issn.1819-6187.2016.03.169.
Deuel TF, Huang JS, Proffitt RT, et al. Human platelet-derived growth factor. Purification and resolution into two active protein fractions. J Biol Chem. 1981;256:8896–9.
Li X, Eriksson U. Novel PDGF family members: PDGF-C and PDGF-D. Cytokine Growth Factor Rev. 2003;14(2):91–8.
Reigstad L, Varhaug J, Lillehaug J. Structural and functional specificities of PDGF-C and PDGF-D, the novel members of the platelet-derived growth factors family. FEBS J. 2005;272(22):5723–41.
Pierce GF, Mustoe TA, Altrock BW, et al. Therapeutic application of growth factors. J Cell Biochem. 1991;45:319–65. doi:10.1002/jcb.240450403.
Hsu C, Chang J. Clinical implications of growth factors in flexor tendon wound healing. J Hand Surg Am. 2004;29:551–63. doi:10.1016/j.jhsa.2004.04.020.
Kiritsy CP, Lynch AB, Lynch SE. Role of growth factors in cutaneous wound healing: a review. Crit Rev Oral Biol Med. 1993;4:729–60.
Massagué J. TGF-beta signal transduction. Annu Rev Biochem. 1998;67:753–91. doi:10.1146/annurev.biochem.67.1.753.
Lind M. Growth factors: possible new clinical tools. A review. Acta Orthop Scand. 1996;67:407–17.
Huang SS, Huang JS. TGF-beta control of cell proliferation. J Cell Biochem. 2005;96:447–62. doi:10.1002/jcb.20558.
Narola J, Pandey SN, Glick A, Chen Y-W. Conditional expression of TGF-β1 in skeletal muscles causes endomysial fibrosis and myofibers atrophy. PLoS One. 2013;8:e79356. doi:10.1371/journal.pone.0079356.
Mohan S, Baylink DJ. Bone growth factors. Clin Orthop Relat Res. 1991;263:30–48.
Canalis E. Clinical review 35: growth factors and their potential clinical value. J Clin Endocrinol Metab. 1992;75:1–4. doi:10.1210/jcem.75.1.1618994.
Bennett NT, Schultz GS. Growth factors and wound healing: biochemical properties of growth factors and their receptors. Am J Surg. 1993;165:728–37.
Tureckova J, Wilson EM, Cappalonga JL, Rotwein P. Insulin-like growth factor-mediated muscle differentiation: collaboration between phosphatidylinositol 3-kinase-Akt-signaling pathways and myogenin. J Biol Chem. 2001;276:39264–70. doi:10.1074/jbc.M104991200.
Jansson KS, Costello KE, O’Brien L, et al. A historical perspective of PCL bracing. Knee Surg Sports Traumatol Arthrosc. 2013;21(5):1064–70.
Kim KJ, Li B, Winer J, et al. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature. 1993;362:841–4. doi:10.1038/362841a0.
Molloy T, Wang Y, Murrell G. The roles of growth factors in tendon and ligament healing. Sports Med. 2003;33:381–94.
Arsic N, Zacchigna S, Zentilin L, et al. Vascular endothelial growth factor stimulates skeletal muscle regeneration in vivo. Mol Ther. 2004;10:844–54. doi:10.1016/j.ymthe.2004.08.007.
Fujio Y, Guo K, Mano T, et al. Cell cycle withdrawal promotes myogenic induction of Akt, a positive modulator of myocyte survival. Mol Cell Biol. 1999;19:5073–82.
Bodine SC, Stitt TN, Gonzalez M, et al. Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nat Cell Biol. 2001;3:1014–9. doi:10.1038/ncb1101-1014.
Nico B, Mangieri D, Benagiano V, et al. Nerve growth factor as an angiogenic factor. Microvasc Res. 2008;75:135–41. doi:10.1016/j.mvr.2007.07.004.
Kawamoto K, Matsuda H. Nerve growth factor and wound healing. Prog Brain Res. 2004;146:369–84. doi:10.1016/S0079-6123(03)46023-8.
Anitua E, Andía I, Sanchez M, et al. Autologous preparations rich in growth factors promote proliferation and induce VEGF and HGF production by human tendon cells in culture. J Orthop Res. 2005;23:281–6. doi:10.1016/j.orthres.2004.08.015.
Nayeri F, Olsson H, Peterson C, Sundqvist T. Hepatocyte growth factor; expression, concentration and biological activity in chronic leg ulcers. J Dermatol Sci. 2005;37:75–85. doi:10.1016/j.jdermsci.2004.11.002.
Acknowledgements
We thank Laura Rivilla for the designing and drawing, Sue-Sonia Tizol for assistance with translation, and all the patients whose images are shown in this chapter. And finally, we would also like to show our gratitude to Professor Doctor Alfonso Blanco for the electron microscopy observations.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 ISAKOS
About this chapter
Cite this chapter
Cugat, R. et al. (2017). Understanding Scaffolds, Stem Cells, and Growth Factors. In: Gobbi, A., Espregueira-Mendes, J., Lane, J., Karahan, M. (eds) Bio-orthopaedics. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-54181-4_12
Download citation
DOI: https://doi.org/10.1007/978-3-662-54181-4_12
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-54180-7
Online ISBN: 978-3-662-54181-4
eBook Packages: MedicineMedicine (R0)